Works matching DE "DISOPYRAMIDE"

Results: 89

Uso de disopiramida para el tratamiento de calambres musculares.

Published in:

Revista Mexicana de Neurociencia, 2013, v. 14, n. 1, p. 14

By:

Marfil-Rivera, Alejandro;
Marfil-Rivera, Luis Javier;
Siller-Reyes, María Fernanda;
Garza-Martínez, Ana Teresa;
De la Cruz-González, Juan Gilberto

Publication type:

Article

Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide.

Published in:

2012

By:

Asajima, Hiroshi;
Saito, Naotaka;
Ohmura, Yoshinori;
Ohmura, Kazue

Publication type:

Letter

Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patients.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2005, v. 30, n. 4, p. 401, doi. 10.1111/j.1365-2710.2005.00668.x

By:

Yukawa, E.;
Orio, K.;
Yukawa, M.;
Terao, K.;
Kinoshita, H.

Publication type:

Article

Contemporary Treatment of Hypertrophic Cardiomyopathy.

Published in:

Texas Heart Institute Journal, 2009, v. 36, n. 3, p. 194

By:

Marian, Ali J.

Publication type:

Article

Deglutition-Induced Atrial Fibrillation.

Published in:

Texas Heart Institute Journal, 2005, v. 32, n. 4, p. 602

By:

Malik, Amyn;
Ali, Syed Sohail;
Rahmatullah, Amin

Publication type:

Article

Effect of Disopyramide on Left Ventricular Pressure Gradient in Hypertrophic Obstructive Cardiomyopathy in Comparison with Propranolol.

Published in:

Angiology, 1999, v. 50, n. 4, p. 331, doi. 10.1177/000331979905000410

By:

Tokudome, Takeshi;
Mizushige, Katsufumi;
Ueda, Takashi;
Sakamoto, Seiji;
Matsuo, Hirohide

Publication type:

Article

Effects of HNS-32, a Novel Antiarrhythmic Agent, on Guinea-Pig Myocardium.

Published in:

Pharmacology, 2002, v. 64, n. 1, p. 36, doi. 10.1159/000056148

By:

Noguchi, Kazuo;
Kase, Junya;
Saitoh, Mariko;
Masumiya, Haruko;
Saitoh, Masaki;
Nakazawa, Tomoo;
Tanaka, Yoshio;
Tanaka, Hikaru;
Hashimoto, Keitaro;
Shigenobu, Koki

Publication type:

Article

The Efficacy and Tolerability of Commonly Used Agents to Prevent Recurrence of Atrial Fibrillation After Successful Cardioversion.

Published in:

American Journal of Cardiovascular Drugs, 2014, v. 14, n. 4, p. 241, doi. 10.1007/s40256-014-0064-5

By:

Gonna, Hanney;
Gallagher, Mark

Publication type:

Article

Differential binding of disopyramide and warfarin enantiomers to human α<sub>1</sub>-acid glycoprotein variants.

Published in:

British Journal of Clinical Pharmacology, 2003, v. 56, n. 6, p. 664, doi. 10.1046/j.1365-2125.2003.01909.x

By:

Nakagawa, T.;
Kishino, S.;
Itoh, S.;
Sugawara, M.;
Miyazaki, K.

Publication type:

Article

A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00213-y

By:

Ogawa, Yukari;
Hirai, Toshinori;
Mihara, Kiyoshi

Publication type:

Article

Electrochemical Oxidation at a Glassy Carbon Electrode of the Anti-Arrhythmia Drug Disopyramide.

Published in:

Analytical Letters, 2007, v. 40, n. 15, p. 2860, doi. 10.1080/00032710701564151

By:

Diculescu, VictorC.;
Enache, TeodorAdrian;
Oliveira‐Brett, AnaMaria

Publication type:

Article

In vivo Effects of Mutant HERG K<sup>+</sup> Channel Inhibition by Disopyramide in Patients with a Short QT-1 Syndrome: A Pilot Study.

Published in:

Journal of Cardiovascular Electrophysiology, 2007, v. 18, n. 11, p. 1157, doi. 10.1111/j.1540-8167.2007.00925.x

By:

SCHIMPF, RAINER;
VELTMANN, CHRISTIAN;
GIUSTETTO, CARLA;
GAITA, FIORENZO;
BORGGREFE, MARTIN;
WOLPERT, CHRISTIAN

Publication type:

Article

Differences in Healthcare Resource Use and Cost by Pharmacotherapy Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of Claims Data.

Published in:

American Journal of Cardiovascular Drugs, 2024, v. 24, n. 6, p. 801, doi. 10.1007/s40256-024-00674-0

By:

Butzner, Michael;
Papademetriou, Eros;
Potluri, Ravi;
Liu, Xing;
Shreay, Sanatan

Publication type:

Article

Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Published in:

American Journal of Cardiovascular Drugs, 2023, v. 23, n. 5, p. 519, doi. 10.1007/s40256-023-00599-0

By:

Sebastian, Sneha Annie;
Padda, Inderbir;
Lehr, Eric J.;
Johal, Gurpreet

Publication type:

Article

Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside.

Published in:

Drugs, 2022, v. 82, n. 8, p. 889, doi. 10.1007/s40265-022-01728-w

By:

Palandri, Chiara;
Santini, Lorenzo;
Argirò, Alessia;
Margara, Francesca;
Doste, Ruben;
Bueno-Orovio, Alfonso;
Olivotto, Iacopo;
Coppini, Raffaele

Publication type:

Article

Pilsicainide.

Published in:

2010

By:

Plosker GL

Publication type:

Journal Article

Disopyramide use in infants and children with hypertrophic cardiomyopathy.

Published in:

2018

By:

O’Connor, Matthew J.;
Miller, Kelley;
Shaddy, Robert E.;
Lin, Kimberly Y.;
Hanna, Brian D.;
Ravishankar, Chitra;
Rossano, Joseph W.;
O'Connor, Matthew J

Publication type:

journal article

Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report.

Published in:

BMC Oral Health, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12903-019-0963-6

By:

Shimoda, Hajime;
Takahashi, Tetsu

Publication type:

Article

Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.

Published in:

Pharmacotherapy, 2015, v. 35, n. 12, p. 1164, doi. 10.1002/phar.1664

By:

Verlinden, Nathan J.;
Coons, James C.

Publication type:

Article

Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide.

Published in:

Heart & Vessels, 2015, v. 30, n. 5, p. 604, doi. 10.1007/s00380-014-0534-3

By:

Haruki, Shintaro;
Minami, Yuichiro;
Suzuki, Atsushi;
Hagiwara, Nobuhisa

Publication type:

Article

天然环肽auyuittuqamide A 的全合成研究.

Published in:

Journal of Pharmaceutical Practice & Service, 2022, v. 40, n. 1, p. 53, doi. 10.12206/j.issn.1006-0111.202105087

By:

耿晨晨;
汪甜甜;
李翔;
王小彦;
姜云云

Publication type:

Article

Folate-conjugated pH-controllable fluorescent nanomicelles acting as tumor targetable drug carriers.

Published in:

Microchimica Acta, 2017, v. 184, n. 8, p. 2881, doi. 10.1007/s00604-017-2255-7

By:

Hao, Weiju;
Wang, Tong;
Liu, Danyang;
Shang, Yazhuo;
Zhang, Junqi;
Xu, Shouhong;
Liu, Honglai

Publication type:

Article

In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.

Published in:

PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179515

By:

Luo, Cunjin;
Wang, Kuanquan;
Zhang, Henggui

Publication type:

Article

Some cardiovascular problems with disopyramide.

Published in:

1980

By:

Warrington, S. J.;
Hamer, J.

Publication type:

journal article

Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Published in:

MEDSURG Nursing, 2012, v. 21, n. 3, p. 129

By:

Berryman, Sandra N.;
Jennings, Joy;
Ragsdale, Sue;
Lofton, Tiffany;
Huff, Debbie Cooley;
Rooker, Janet Smith

Publication type:

Article

Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide.

Published in:

Xenobiotica, 2001, v. 31, n. 2, p. 73, doi. 10.1080/00498250110037488

By:

Zhang, L.;
Fitzloff, J. F.;
Engel, L. C.;
Cook, C. S.

Publication type:

Article

Long-Term Use of Controlled-Release Disopyramide in Patients with Severe Ventricular Arrhythmias.

Published in:

Angiology, 1987, v. 38, p. 198

By:

Paulk Jr., E. Alan

Publication type:

Article

The Pharmacokinetic and Pharmacodynamic Effects of Varying the Free Fraction of Disopyramide.

Published in:

Angiology, 1987, v. 38, p. 192

By:

Shaw, Leslie M.;
Doherty, John U.;
Waxman, Harvey L.;
Josephson, Mark E.

Publication type:

Article

Transfer from Immediate-Release Disopyramide to Controlled-Release Disopyramide.

Published in:

Angiology, 1987, v. 38, p. 188

By:

DiPersio, David M.;
Chow, Moses S. S.

Publication type:

Article

Pharmacologic Evaluation of Standard and Controlled-Release Disopyramide.

Published in:

Angiology, 1987, v. 38, p. 184

By:

Siddoway, Lyle A.;
Barbey, J. Toby;
Roden, Dan M.;
Woosley, Raymond L.

Publication type:

Article

A Review of the Effects of Disopyramide Phosphate on Left Ventricular Function and the Peripheral Circulation.

Published in:

Angiology, 1987, v. 38, p. 174

By:

Di Bianco, Robert;
Gottdiener, John S.;
Singh, Steven N.;
Fletcher, Ross D.

Publication type:

Article

The Clinical Scope of Disopyramide Seven Years After Introduction -- An Overview.

Published in:

Angiology, 1987, v. 38, p. 165

By:

Willis III, Park W.

Publication type:

Article

The Anticholinergic Side Effects of Disopyramide and Controlled-Release Disopyramide.

Published in:

Angiology, 1985, v. 36, n. 11, p. 767, doi. 10.1177/000331978503601101

By:

Teichman, Sam

Publication type:

Article

A Randomized, Double-Blind, Parallel Group Comparison of Disopyramide Phosphate and Quinidine in Patients with Cardiac Arrhythmias.

Published in:

Angiology, 1983, v. 34, n. 6, p. 393, doi. 10.1177/000331978303400603

By:

Arif, Mohammed;
Laidlaw, James C.;
Oshrain, Carl;
Willis III, Park W.;
Nissen, Catherine H.;
McDermott, Daniel J.;
Smith, W. Scott;
Karim, Aziz;
Wilson, Richard R.

Publication type:

Article

Disopyramide Plasma Concentrations Following Single and Multiple Doses of the Immediate- and Controlled-Release Capsules.

Published in:

Angiology, 1983, v. 34, n. 6, p. 375, doi. 10.1177/000331978303400602

By:

Karim, Aziz;
Schubert, Elliot N.;
Burns, Thomas S.;
Palmer, Michael;
Zinny, M. A.

Publication type:

Article

Disopyramide: Six Years' Experience.

Published in:

Angiology, 1983, v. 34, n. 6, p. 367, doi. 10.1177/000331978303400601

By:

Wilson, Richard R.;
Wallace, Andrew G.

Publication type:

Article

THE ELECTROPHYSIOLOGY OF NORPACE (PART III).

Published in:

Angiology, 1975, v. 26, p. 120

By:

Caracta, Anthony

Publication type:

Article

THE PHARMACOLOGY OF NORPACE.

Published in:

Angiology, 1975, v. 26, p. 67

By:

Dean, Richard Raymond

Publication type:

Article

Repolarization Abnormality in Idiopathic Ventricular Fibrillation: Assessment Using 24-Hour QT-RR and QaT-RR Relationships.

Published in:

Journal of Cardiovascular Electrophysiology, 2004, v. 15, n. 1, p. 59, doi. 10.1046/j.1540-8167.2004.03396.x

By:

FUJIKI, AKIRA;
SUGAO, MASATAKA;
NISHIDA, KUNIHIRO;
SAKABE, MASAO;
TSUNEDA, TAKAYUKI;
MIZUMAKI, KOICHI;
INOUE, HIROSHI

Publication type:

Article

Effect of Sodium Channel Blockers on ST Segment, QRS Duration, and Corrected QT Interval in Patients with Brugada Syndrome.

Published in:

Journal of Cardiovascular Electrophysiology, 2000, v. 11, n. 12, p. 1320, doi. 10.1046/j.1540-8167.2000.01320.x

By:

Shimizu, Wataru;
Antzelevitch, Charles;
Suyama, Kazuhiro;
Kurita, Takashi;
Taguchi, Atsushi;
Aihara, Naohiko;
Takaki, Hiroshi;
Sunagawa, Kenji;
Kamakura, Shiro

Publication type:

Article

Overdrive Suppression of Antegrade Conduction Over A Kent Bundle Induced by Disopyramide.

Published in:

Journal of Cardiovascular Electrophysiology, 1990, v. 1, n. 6, p. 512, doi. 10.1111/j.1540-8167.1990.tb01085.x

By:

Inoue, Hiroshi;
Saihara, Shinichiro;
Usui, Masahiro;
Toda, Iku;
Nozaki, Akira;
Sugimoto, Tsuneaki

Publication type:

Article

Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant.

Published in:

Drugs in R&D, 2017, v. 17, n. 3, p. 475, doi. 10.1007/s40268-017-0193-9

By:

Kazuhiko Hanada

Publication type:

Article

Disopyramide and inducible arrhythmias.

Published in:

1991

By:

Stanton, M S

Publication type:

commentary

Disopyramide.

Published in:

1982

By:

Morady, Fred;
Scheinman, Melvin M.;
Desai, Jawahar;
Morady, F;
Scheinman, M M;
Desai, J

Publication type:

journal article

Myocardial depression with disopyramide.

Published in:

1981

By:

Bauman, D J

Publication type:

Case Study

Thioridazine-associated ventricular tachycardia and isoproterenol.

Published in:

1981

By:

Pietro, D A

Publication type:

Case Study

Disopyramide and cholestasis.

Published in:

1980

By:

Craxi, A;
Gatto, G;
Maringhini, A;
Orsini, S;
Pinzello, G;
Pagliaro, L

Publication type:

Case Study

Multiple treatment comparisons in epilepsy monotherapy trials.

Published in:

Trials, 2007, v. 8, p. 34, doi. 10.1186/1745-6215-8-34

By:

Smith, Catrin Tudur;
Marson, Anthony G.;
Chadwick, David W.;
Williamson, Paula R.

Publication type:

Article

Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice.

Published in:

2010

By:

Miyamoto, Kanyu;
Kawai, Hirohisa;
Aoyama, Ryuhei;
Watanabe, Hitoshi;
Suzuki, Keisuke;
Suga, Norihiro;
Kitagawa, Wataru;
Miura, Naoto;
Nishikawa, Kazuhiro;
Imai, Hirokazu

Publication type:

Report

DISOPYRAMIDE-INDUCED NEUROPATHY.

Published in:: Journal of the Peripheral Nervous System, 2002, v. 7, n. 1, p. 71, doi. 10.1046/j.1529-8027.2002.7011_5.x
Publication type:: Article